Osiris Therapeutics, Inc. the leading stem cell company focused on developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets, announced today its results for the fourth quarter and full year ended December 31, 2012.
http://www.sys-con.com/node/2567532
http://www.sys-con.com/node/2567532
No comments:
Post a Comment